RxDoctor Payments Data

Michael Thompson, MD

Psychiatry · Louisville, KYNPI 1457490849

Payments from drug & device makers

$547in general payments, 2019–2025

Across 34 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$86
  • Alkermes, Inc.$75
  • Otsuka America Pharmaceutical, Inc.$63
  • Takeda Pharmaceuticals U.S.A., Inc.$52
  • Vanda Pharmaceuticals Inc.$50
  • Shire North American Group Inc$49
  • plus $172 from 6 others

What the payments were for

  • Food & beverage$50091%
  • Education$479%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$547 in reported general payments places this provider in the 60th percentile of 348 psychiatry providers in Kentucky.

See all psychiatry providers in Kentucky

Medicare billing

Part B allowed, 2024
$22,557
Medicare patients
85
Services billed
243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate75$219,764
Abilify MaintenaAripiprazole27$70,415
VraylarCariprazine Hcl42$62,843
TrintellixVortioxetine Hydrobromide87$52,215
Aripiprazole379$47,685
Lurasidone Hcl147$47,683
FanaptIloperidone21$45,071
Paliperidone ErPaliperidone66$20,958
RexultiBrexpiprazole14$20,166
Asenapine Maleate34$9,787
Quetiapine Fumarate543$9,305
Oxcarbazepine181$7,892
Clozapine93$7,874
Quetiapine Fumarate ErQuetiapine Fumarate66$6,954
CymbaltaDuloxetine Hcl12$6,929

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$86$219,76475 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$63$90,58141 claims
AbbVieVraylar, Fetzima$29$69,37155 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$52$58,285102 claims
Vanda Pharmaceuticals Inc.Fanapt$50$45,07121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 348 psychiatry providers in Kentucky.

Other psychiatry in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →